Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Fourie 2015 Abstract MiPschool Cape Town 2015"

From Bioblast
(Created page with "{{Abstract |year=2015 |event=MiPschool Cape Town 2015 }} {{Labeling}}")
Β 
Line 1: Line 1:
{{Abstract
{{Abstract
|title=The association of Coenzyme Q10- deficiencies and respiratory chain disorders in South African patients.
|authors=Fourie J
|year=2015
|year=2015
|event=MiPschool Cape Town 2015
|event=MiPschool Cape Town 2015
|abstract=Coenzyme Q10 (CoQ10), an essential component of the respiratory chain, shuttles electrons from complex I and II to complex III. CoQ10 deficiencies are therefore often associated with respiratory chain disorders. CoQ10 deficiencies are heterogeneous and affected patients have varying degrees of CoQ10 shortage. The aim of this study was to determine the association of defects in the biosynthesis of CoQ10 and associated respiratory chain deficiencies in South Africa patients. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was standardized in order to quantify CoQ10 in muscle samples, using a stable isotope dilution approach. The quantification of CoQ10 was then performed on muscle specimens of patients (n=155) that clinically qualified for electron transport chain analyses. Seventy nine were clinically referred controls and 76 had confirmed respiratory chain deficiencies of which 29 patients had CII+III deficiencies. Ion torrent next generation sequencing was performed on 24 patients including 9 patients with decreased as well as 15 patients with normal CoQ10 levels. Eighteen targeted genes involved in primary and secondary CoQ10 were sequenced. Eight patients, all with combined complex II+II deficiencies had deficient CoQ10 concentrations in muscle samples. Sixteen possible disease-causing variants were identified. Three compound heterozygous variants in three patients with low CoQ10 levels were found in the ETFDH, COQ6 and COQ7 genes respectively. Pathogenicity was proven in the ETFDH and COQ6 genes. To conclude, only mitochondrial patients with confirmed CII +III enzyme deficiencies had statistically significant low CoQ10 levels and at least two patients had pathogenic novel mutations in the ETFDH and COQ6 genes.
}}
}}
{{Labeling}}
{{Labeling
|area=Respiration, Instruments;methods, mtDNA;mt-genetics, mt-Medicine, Patients
|organism=Human
|tissues=Skeletal muscle
|enzymes=Complex I, Complex II; Succinate Dehydrogenase, Complex III, TCA Cycle and Matrix Dehydrogenases
|injuries=Mitochondrial Disease; Degenerative Disease and Defect
|additional=CoQ10
}}
== Affiliations ==
North-West Univ, Potchefstroom Campus, South Africa

Revision as of 17:07, 6 February 2015

The association of Coenzyme Q10- deficiencies and respiratory chain disorders in South African patients.

Link:

Fourie J (2015)

Event: MiPschool Cape Town 2015

Coenzyme Q10 (CoQ10), an essential component of the respiratory chain, shuttles electrons from complex I and II to complex III. CoQ10 deficiencies are therefore often associated with respiratory chain disorders. CoQ10 deficiencies are heterogeneous and affected patients have varying degrees of CoQ10 shortage. The aim of this study was to determine the association of defects in the biosynthesis of CoQ10 and associated respiratory chain deficiencies in South Africa patients. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was standardized in order to quantify CoQ10 in muscle samples, using a stable isotope dilution approach. The quantification of CoQ10 was then performed on muscle specimens of patients (n=155) that clinically qualified for electron transport chain analyses. Seventy nine were clinically referred controls and 76 had confirmed respiratory chain deficiencies of which 29 patients had CII+III deficiencies. Ion torrent next generation sequencing was performed on 24 patients including 9 patients with decreased as well as 15 patients with normal CoQ10 levels. Eighteen targeted genes involved in primary and secondary CoQ10 were sequenced. Eight patients, all with combined complex II+II deficiencies had deficient CoQ10 concentrations in muscle samples. Sixteen possible disease-causing variants were identified. Three compound heterozygous variants in three patients with low CoQ10 levels were found in the ETFDH, COQ6 and COQ7 genes respectively. Pathogenicity was proven in the ETFDH and COQ6 genes. To conclude, only mitochondrial patients with confirmed CII +III enzyme deficiencies had statistically significant low CoQ10 levels and at least two patients had pathogenic novel mutations in the ETFDH and COQ6 genes.


Labels: MiParea: Respiration, Instruments;methods, mtDNA;mt-genetics, mt-Medicine, Patients 

Stress:Mitochondrial Disease; Degenerative Disease and Defect"Mitochondrial Disease; Degenerative Disease and Defect" is not in the list (Cell death, Cryopreservation, Ischemia-reperfusion, Permeability transition, Oxidative stress;RONS, Temperature, Hypoxia, Mitochondrial disease) of allowed values for the "Stress" property.  Organism: Human  Tissue;cell: Skeletal muscle 

Enzyme: Complex I, Complex II; Succinate Dehydrogenase"Complex II; Succinate Dehydrogenase" is not in the list (Adenine nucleotide translocase, Complex I, Complex II;succinate dehydrogenase, Complex III, Complex IV;cytochrome c oxidase, Complex V;ATP synthase, Inner mt-membrane transporter, Marker enzyme, Supercomplex, TCA cycle and matrix dehydrogenases, ...) of allowed values for the "Enzyme" property., Complex III, TCA Cycle and Matrix Dehydrogenases"TCA Cycle and Matrix Dehydrogenases" is not in the list (Adenine nucleotide translocase, Complex I, Complex II;succinate dehydrogenase, Complex III, Complex IV;cytochrome c oxidase, Complex V;ATP synthase, Inner mt-membrane transporter, Marker enzyme, Supercomplex, TCA cycle and matrix dehydrogenases, ...) of allowed values for the "Enzyme" property. 



CoQ10 

Affiliations

North-West Univ, Potchefstroom Campus, South Africa